Case File
efta-01360683DOJ Data Set 10OtherEFTA01360683
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01360683
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
I Subject:
I
IRe: J. Epstein KYC Updates: Additional signer [I]
classification: For internal use only
understand the broadness of the letter but I don't see how darren could be
added as Jeffrey is not authorized on her accounts. It would be impossible to
add him to that account without her signature. Is that not sufficient for the
kyc purposes?
original message
From: Janice Franklin
Sent: 03/03/2014 02:05 PM EST
To: Amanda Kirby
Cc: Jacqueline Lightbody
Subject: Re: J. Epstein KYC updates: Additional signer [I]
Classification: For internal use only
That was my guess. The point I wanted to make is given how the letter is
written Mr. Indyke should be added to
account. why? Because the
letter states ". . . to give Mr. Indyke signing authority . . . on all
accounts associated with the Southern Financial Relationship.
account is associated with the Southern Financial Relationship.
I recommend that Mr. Epstein sends you another letter listing the specific
accounts he wants to update or he could broadly write he would like Mr. Indyke
added to the accounts in his (Mr. Epstein's) name and where he is the ultimate
beneficial owner.
If the instructions are written in this manner,
account would not be an issue.
Regards,
Janice P. Franklin
(Embedded image moved to file: pic07579.gif)
Janice Franklin, CAMS, CFSA, CFIRS
Vice President I AML compliance officer
Deutsche Bank Trust Company Americas
Compliance
60 wall Street. 10005-2836 New York, NY, USA
Tel.
Fax
Emai
(Embedded image moved to file: pic26979.gif)
I From:
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0049189
CONFIDENTIAL
SDNY_GM_00195373
EFTA01360683
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.